(Q34859064)

4 August 2017

1 reference

title

Nesiritide: a new drug for the treatment of decompensated heart failure (English)

1 reference

4 August 2017

1 reference

Uri Elkayam

1

1 reference

4 August 2017

Mohammed Waseem Akhter

2

1 reference

4 August 2017

Priya Tummala

3

1 reference

4 August 2017

Salman Khan

4

1 reference

4 August 2017

Harpreet Singh

5

1 reference

4 August 2017

1 July 2002

1 reference

Journal of Cardiovascular Pharmacology and Therapeutics

4 August 2017

1 reference

4 August 2017

7

1 reference

4 August 2017

3

1 reference

4 August 2017

181-194

1 reference

SPECIFIC GRANULES IN ATRIAL MUSCLE CELLS

4 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F107424840200700308

A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840200700308

Atrial natriuretic factor: a hormone produced by the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840200700308

Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840200700308

Physiology of natriuretic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840200700308

Natriuretic peptides A family of hormones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840200700308

Atrial natriuretic peptide causes pre-glomerular vasodilatation and post-glomerular vasoconstriction in rat kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840200700308

Regulation of filtration rate by glomerular mesangial cells in health and diabetic renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840200700308

Atrial natriuretic peptide inhibits angiotensin-stimulated proximal tubular sodium and water reabsorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840200700308

Inhibition of vasopressin action by atrial natriuretic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840200700308

Regulation of collecting duct Na+ reabsorption by ANP 31-67.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840200700308

Pressor effect of blocking atrial natriuretic peptide in nucleus tractus solitarii

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840200700308

A functional role for endogenous atrial natriuretic peptide in a canine model of early left ventricular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840200700308

Hemodynamic changes and renal plasma flow in early heart failure: implications for renin, aldosterone, norepinephrine, atrial natriuretic peptide and prostacyclin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840200700308

Atrial natriuretic peptide in congestive heart failure in the dog: plasma levels, cyclic guanosine monophosphate, ultrastructure of atrial myoendocrine cells, and hemodynamic, hormonal, and renal effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840200700308

Clinical pharmacokinetics of vasodilators. Part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840200700308

Nesiritide for the treatment of decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840200700308

Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840200700308

Hemodynamic effects of a single intravenous injection of synthetic human brain natriuretic peptide in patients with heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840200700308

Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840200700308

Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. Natrecor Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840200700308

Hemodynamic and renal excretory effects of human brain natriuretic peptide infusion in patients with congestive heart failure. A double-blind, placebo-controlled, randomized crossover trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840200700308

Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840200700308

Tolerance to organic nitrates: evidence, mechanisms, clinical relevance, and strategies for prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840200700308

Neutral Endopeptidase Is Activated in Cardiomyocytes in Human Aortic Valve Stenosis and Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F107424840200700308

10.1177/107424840200700308

21 January 2018

Identifiers

DOI

1 reference

4 August 2017

1 reference